Please login to the form below

Not currently logged in
Email:
Password:

Hanover Health opens market access practice

New practice will be led by director Jing Wang-Silvanto

HanoverHanover Health, part of the wider Hanover communications and public affairs consultancy group, has created a new market access-focused practice at its London and Brussels hubs.

Adding to the health specialist's three existing practices - Health Communications and UK and European Health Policy and Advocacy - Healthcare Market Access will be led by director Jing Wang-Silvanto.

Wang-Silvanto joins the new practice from WG Access, where she was director for value access strategy and head of health economics, and also brings client-side expertise from Bristol-Myers Squibb, GlaxoSmithKline and Novartis.

Her team will offer pricing and managed access, early access and payer engagement, and health technology assessment support for pharma clients across Europe.

Andrew Harrison, Hanover's managing director of health, said: “Health system finances are squeezed and there is increased need for companies to demonstrate the value of their products and services.

“There are plenty of market access consultancies, but Hanover's ability to join market access with award-winning policy, advocacy and communications campaigns provides a unique offer that can bring change for clients.

“Market Access is a natural extension of Hanover's health work. For a while clients have asked the team to support pricing, health economics and early access work.

“Our growth in health in the UK and internationally, and in communications as well as policy, gives us the confidence to invest in expanding our services.”

Article by
Rebecca Clifford

21st December 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics